S. Field

Deuterium nuclear magnetic resonance imaging of the developmental pattern of tumour blood flow.

J. Griffiths, R. Maxwell, I. Burney, 1992, EXS.

The potential for prazosin and calcitonin gene-related peptide (CGRP) in causing hypoxia in tumours.

J. Griffiths, R. Maxwell, I. Burney, 1991, British Journal of Cancer.

The combined measurement of blood flow and metabolism in RIF‐1 tumours in vivo. A study using H2 flow and 31P NMR spectroscopy

S. Williams, S. Williams, Z. Bhujwalla, 1990, NMR in biomedicine.

Effect of vasoactive drugs on tumour blood flow as determined by 2H nuclear magnetic resonance spectroscopy.

J. Griffiths, R. Maxwell, C. McCoy, 1995, Acta oncologica.

The energy metabolism of RIF-1 tumours following hydralazine.

J R Griffiths, G M Tozer, J. Griffiths, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Differences in vascular response between primary and transplanted tumours.

J. Griffiths, R. Maxwell, J. Coggle, 1991, British Journal of Cancer.

Are transplanted tumours suitable as models for studies on vasculature?

J. Griffiths, R. Maxwell, J. Coggle, 1991, International Journal of Radiation Biology.